Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K R Cooke

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|June 20, 2001
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantationK R Cooke, A Gerbitz, J M Crawford, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 5, 2014
Disseminated Bacillus Calmette-Guérin (BCG) infection following allogeneic hematopoietic stem cell transplant in a patient with Bare Lymphocyte Syndrome type IIR F Abu-Arja, B E Gonzalez, M R Jacobs, et al.
Blood|June 11, 1999
Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host diseaseL Pan, T Teshima, G R Hill, et al.
The Journal of Clinical Investigation|August 3, 1999
IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantationT Teshima, G R Hill, L Pan, et al.
Bone Marrow Transplantation|January 31, 1998
Persistence of pulmonary pathology and abnormal lung function in IL-3/GM-CSF/IL-5 beta c receptor-deficient mice despite correction of alveolar proteinosis after BMTK R Cooke, R Nishinakamura, T R Martin, et al.
Transplantation|August 10, 2000
Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantationK R Cooke, G R Hill, A Gerbitz, et al.
Bone Marrow Transplantation|September 23, 2014
Recombinant human keratinocyte growth factor: successful treatment of severe, refractory hemorrhagic cystitis after allogeneic hematopoietic cell transplantationS Bhaskaran, R F Abu-Arja, G Abusin, et al.
The Journal of Clinical Investigation|July 3, 1998
Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantationG R Hill, K R Cooke, T Teshima, et al.
Transplantation|November 15, 1996
Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host diseaseW Krenger, K R Cooke, J M Crawford, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: potential role for a gut-lung axis of inflammationK R Cooke, G R Hill, A Gerbitz, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|June 20, 2001
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantationK R Cooke, A Gerbitz, J M Crawford, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 5, 2014
Disseminated Bacillus Calmette-Guérin (BCG) infection following allogeneic hematopoietic stem cell transplant in a patient with Bare Lymphocyte Syndrome type IIR F Abu-Arja, B E Gonzalez, M R Jacobs, et al.
Blood|June 11, 1999
Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host diseaseL Pan, T Teshima, G R Hill, et al.
The Journal of Clinical Investigation|August 3, 1999
IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantationT Teshima, G R Hill, L Pan, et al.
Bone Marrow Transplantation|January 31, 1998
Persistence of pulmonary pathology and abnormal lung function in IL-3/GM-CSF/IL-5 beta c receptor-deficient mice despite correction of alveolar proteinosis after BMTK R Cooke, R Nishinakamura, T R Martin, et al.
Transplantation|August 10, 2000
Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantationK R Cooke, G R Hill, A Gerbitz, et al.
Bone Marrow Transplantation|September 23, 2014
Recombinant human keratinocyte growth factor: successful treatment of severe, refractory hemorrhagic cystitis after allogeneic hematopoietic cell transplantationS Bhaskaran, R F Abu-Arja, G Abusin, et al.
The Journal of Clinical Investigation|July 3, 1998
Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantationG R Hill, K R Cooke, T Teshima, et al.
Transplantation|November 15, 1996
Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host diseaseW Krenger, K R Cooke, J M Crawford, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: potential role for a gut-lung axis of inflammationK R Cooke, G R Hill, A Gerbitz, et al.
Pageof 6